(1)
A Sensitive Bioanalytical Method Development And Validation Of Pazopanib In Human Plasma By LC-ESI-MS MS. Journal of Pharmaceutical Negative Results 2022, 855-861. https://doi.org/10.47750/pnr.2022.13.S09.102.